Nanosphere Submits Application to FDA for Respiratory Virus Assay | GenomeWeb

NEW YORK (GenomeWeb News) – Nanosphere today said that it has filed a 510(k) application to the US Food and Drug Administration for marketing clearance of its Verigene SP Respiratory Virus Assay.

The assay detects influenza and respiratory syncytial virus and runs on the firm's Verigene SP system, an automated sample-to-result molecular diagnostic instrument. The Verigene SP is a newer version of the firm's first-generation Verigene system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.